(Q40093033)

English

EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer

scientific article published on 9 May 2008

In more languages
default for all languages
No label defined

No description defined

Statements

EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer (English)
0 references
0 references
Rob Glynne-Jones
Alec C McDonald
National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit